Skip to content
Product Line: Pharmaceutical Chemicals

Lenalidomide

CAS 191732-72-6

Molecular structure of Lenalidomide

CAS · 191732-72-6

01

Product Overview

Lenalidmide丨191732-72-6 is a synthetic derivative f thalidmide, belnging t the class f immunmdulatry drugs (IMiDs). It is used primarily in the treatment f hematlgical cancers and autimmune diseases due t its ability t mdify the immune system and target cancer cells.

02

Product Specifications

Property Specification
Appearance Off-white to light yellow powder
Purity 99.5% min
Water 4% max
Total Impurities 0.5% max
Residue on Ignition 0.1% max
Heavy Metals 10 ppm max
Pd 10 ppm max
03

Applications

Detailed application notes for this product are available on request. Contact our technical team for the full application dossier, formulation guidance and regulatory documentation.

04

Benefits

1. Effective Anti-Cancer Prperties

● Lenalidmide丨191732-72-6 wrks by mdulating the immune system, enhancing the bdy's ability t attack cancer cells, particularly in cnditins like multiple myelma and mantle cell lymphma.

2. Imprved Quality f Life in Cancer Patients

● It reduces symptms and imprves verall quality f life fr patients with bld cancers by lwering the need fr transfusins and prmting red bld cell prductin in MDS.

3. Immune System Mdulatin

● Lenalidmide enhances immune respnses by increasing T-cell functin and prducing cytkines, which play a critical rle in the fight against cancer and autimmune diseases.

4. ral Administratin and Cnvenience

● It is administered rally, prviding cnvenience ver intravenus therapies, which is an advantage fr lng-term treatment regimens.

5. Brad Applicatins in Cancer and Autimmune Disrders

● Lenalidmide has shwn prmise in treating varius cancers and autimmune cnditins, and its research cntinues t uncver additinal ptential uses.

05

Conclusion

Lenalidmide丨191732-72-6 is an imprtant immunmdulatry drug with effective applicatins in treating hematlgical cancers like multiple myelma and myeldysplastic syndrmes. It als shws prmise in autimmune disease management. Its ability t mdulate the immune system, target cancer cells, and imprve patient utcmes makes it a vital therapeutic tl in mdern medicine.

Previous

Spiramycin丨CAS 8025-81-8

Next

D-chiro-Inositol丨CAS 643-12-9